Zhong Huijuan, one of the richest women in the world, has paved the way for China’s new list of the richest people in fitness care published in Forbes China’s most recent factor, the Chinese edition of Forbes.
Zhong, 59, chairs Hansoh Pharmaceutical Group, a Hong Kong-listed provider of cancer and diabetes treatments. Zhong had an estimated fortune of $19.8 billion as of July 17, the pricing date for the new list. This compares to his $14.6 billion fortune on Forbes’ 2020 multimillion-dollar list at the March 18 price.
China’s stocks of medicines, medical devices and medical devices are declining this year, as sales of the COVID-19 pandemic attract global attention to the country’s top suppliers.
At the total of the 10 most sensitive on the new list, with his fortune, were: Li Xiting, $17.5 billion, the president and co-founder of Shenzhen Mindray Bio-Medical Electronics, who has lately been a citizen of Singapore; Sun Piaoyang, $16.8 billion, president of Jiangsu Hengrui Medicine, who is also the husband of Zhong Huijuan; Xu Hang, $16.3 billion, co-founder and director of Mindray; Jiang Rensheng, $16 billion, president of Chongqing Zhifei Biological Products; Zhong Shanshan, $12.1 billion, Beijing’s majority shareholder Wantai Organic Pharmacy; Chen Bang, $11.5 billion, president of Aier Eye Hospital; Tse Ping, $10.9 billion, CEO of Sino Biopharmaceutical; Cen Junda, $10.7 billion, which has a stake in Hansoh; and Li Ge, $9 billion, president of WuXi Apptec. Click here to see the full ranking.
The list included executives from Chinese-based corporations and was based on monetary and percentage holders data received from Chinese families and individuals, inventory exchanges, analysts and regulatory agencies. The rating lists the individual fortunes and the circle of relatives, adding the percentages between the founders of the company and their enjoyed. Public fortunes were calculated based on percentage costs and exchange rates as of July 17. Private corporations have been assessed on the basis of similar publicly traded corporations.
View similar articles:
Chinese drug manufacturers’ stocks go up under COVID-19 vaccine pact with AstraZeneca
The expansion of surgeries generates a new Chinese billionaire
Shanghai drug manufacturer $97 million of Fidelity, Qiming and others
Note: COVID-19 is in the headlines around the world this year, but cancer will kill more people around the world. Forbes China will launch its first “Forbes China Health Summit” on August 15, 2020 (August 14, 2020 in the United States). The theme is “Advancing the global fight against cancer in the COVID-19 pandemic”. The occasion released online is in English; Here are more important points.
– with Maggie Chen and Elaine Mao
“Follow me to rflannerychina
I’m editor-in-chief and director of Forbes magazine’s Shanghai office. Now, in my year at Forbes, I’m compiling Forbes’ China Rich List. I used to be a
I’m editor-in-chief and director of Forbes magazine’s Shanghai office. Now, in my twentieth year at Forbes, I’m compiling Forbes’ China Rich List. In the past I was a correspondent for Bloomberg News in Taipei and Shanghai and the Asian Wall Street Journal in Taipei. I am originally from Massachusetts, speak Mandarin fluently and graduated from the University of Vermont and the University of Wisconsin at Madison.